MNC Pharma firms step on the gas
Following the buyout of India’s largest pharma firm Ranbaxy by Japan’s Daiichi and RFCL’s animal healthcare business by Pfizer, Businessworld has a cover story on how and why the big…
Following the buyout of India’s largest pharma firm Ranbaxy by Japan’s Daiichi and RFCL’s animal healthcare business by Pfizer, Businessworld has a cover story on how and why the big…
In an article for the Economic Times, Arun Duggal, the former Indian CEO of Bank of America and a board member of several Indian financial services companies, has a set…
Extract from the profile of Kolkata-based branded menswear firm Turtle Limited: Turtle has just reported a turnover of Rs 62 crore, its highest ever, in 2008-09, up from Rs 46…
In a recent Business Standard column, former Chief Economic Adviser Shankar Acharya has expressed unease – from the perspective of the economy – at the way the new UPA government…
The new UPA government’s first policy statement – the presidential address (PA) to Parliament – gives Business Standard columnist and former Chief Economic Adviser Shankar Acharya a feeling that this…
Evolvence India Life Sciences Fund (EILSF) has committed to invest upto Rs. 25 Crore in Anjan Drugs Pvt. Ltd., a Chennai-based pharmaceuticals company specializing in medicines to treat Central Nervous…
Hyderabad-based green energy firm Shalivahana Green Energy Ltd. has raised Rs. 90 crore ($18 million) from Axis Private Equity and IL&FS Financial Services. Shalivahana is a renewable energy firm focused…
Businessworld has an article on engineering & construction firm HCC’s ambitious hill station project. HCC entered real estate development in 2001 when it kicked off land acquisition for the Lavasa…
Harvard University Prof and former IMF chief economist weighs in via his Businessworld column. US consumption, the single-biggest driver of global growth, is surely headed to a lower level, on…
In his column for the Economic Times, Morgan Stanley’s Ruchir Sharma explains why the structural issues relating to the “over-indebted US consumer and the export-dependent Chinese manufacturer” will come back…